Obesity-related, metabolic asthma: a new role for glucagon-like peptide 1 agonists

Lancet Respir Med. 2017 Mar;5(3):162-164. doi: 10.1016/S2213-2600(17)30051-6.

Authors

Dan-Vinh Nguyen¹, Angela Linderholm², Angela Haczku², Nicholas Kenyon²

Affiliations

¹ Department of Internal Medicine, Division of Pulmonary, Critical Care, and Sleep Medicine, University of California Davis, Sacramento, CA 95817, USA. Electronic address: dvpnguyen@ucdavis.edu.
² Department of Internal Medicine, Division of Pulmonary, Critical Care, and Sleep Medicine, University of California Davis, Sacramento, CA 95817, USA.

No abstract available

Publication types

Review

MeSH terms

Asthma / complications*
Asthma / drug therapy*
Glucagon-Like Peptide 1 / therapeutic use*
Humans
Metabolic Syndrome / complications*
Obesity / complications*

Substances

Glucagon-Like Peptide 1

Grants and funding